Effect of metformin administration and weight loss on plasma ceramide C16:0, C18:0, C24:1 concentrations in patients with non-alcoholic fatty liver disease associated with insulin resistance and type 2 diabetes
Background. Ceramides are the fats of the sphingolipid family that are involved in the development of insulin resistance, non-alcoholic fatty liver disease, and type 2 diabetes. Despite the standards of treatment for these diseases, there is currently a lack of information regarding their effect on...
Main Author: | L.L. Pavlovskyi |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2020-03-01
|
Series: | Gastroenterologìa |
Subjects: | |
Online Access: | http://gastro.zaslavsky.com.ua/article/view/206227 |
Similar Items
-
C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma
by: Raphael Wilhelm, et al.
Published: (2021-01-01) -
The Role of Ceramides in Insulin Resistance
by: Emilia Sokolowska, et al.
Published: (2019-08-01) -
The Crucial Role of C18-Cer in Fat-Induced Skeletal Muscle Insulin Resistance
by: Agnieszka U. Blachnio-Zabielska, et al.
Published: (2016-12-01) -
Ceramides in Adipose Tissue
by: Ying Li, et al.
Published: (2020-06-01) -
Differential placental ceramide levels during gestational diabetes mellitus (GDM)
by: Juan F. Mejia, et al.
Published: (2019-10-01)